Insulin analogues may accelerate progression of diabetic retinopathy after impairment of inner blood-retinal barrier

Medical Hypotheses

Volumn 81, Issue 6, 2013, Pages 1012-1014

  Kaya, Abdullah ^a   Kar, Taner ^a   Aksoy, Yakup ^b   Özalper, Veysel ^a   Başbuǧ, Barbaros ^a  

^a GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

^b Hakkari Military Hospital   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; GROWTH HORMONE; INSULIN; INSULIN ASPART; INSULIN DERIVATIVE; INSULIN DETEMIR; INSULIN GLARGINE; INSULIN GLULISINE; INSULIN LISPRO; OCTREOTIDE; SOMATOMEDIN C; VISUAL PIGMENT;

ARTICLE; BLOOD RETINA BARRIER; CELL PROLIFERATION; CELL TYPE; CHORIORETINITIS; DIABETIC RETINOPATHY; DISEASE COURSE; EPITHELIUM CELL; FIBROBLAST; GLIA; GLIA CELL; GLUCOSE BLOOD LEVEL; HUMAN; INNER BLOOD RETINAL BARRIER; PERICYTE; PIGMENT EPITHELIUM; RETINA; RETINAL PIGMENT EPITHELIAL CELL; UVEITIS;

BLOOD GLUCOSE; BLOOD-RETINAL BARRIER; DIABETIC RETINOPATHY; GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; INSULINS; MODELS, BIOLOGICAL; RECEPTOR, IGF TYPE 1;

EID: 84888430723     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2013.09.018     Document Type: Article

References (21)

1. Lachin J.M., Genuth S., Nathan D.M., Zinman B., Rutledge B.N. DCCT/EDIC Research Group. Effect of glycemic exposure on the risk of microvascular complications in the diabetes control and complications trial-revisited. Diabetes 2008, 57(4):995-1001. [Epub 2008 Jan 25]. 10.2337/db07-1618.
2. Poulsen J. The houssay phenomenon in man: recovery from retinopathy in a case of diabetes with Simmond's disease. Diabetes 1953, 2:7-12.
3. Murphy R.P., Nanda M., Plotnick L., Enger C., Vitale S., Patz A. The relationship of puberty to diabetic retinopathy. Arch Ophthalmol 1990, 108(2):215-218.
4. Rogers D.G., White N.H., Shalwitz R.A., Palmberg P., Smith M.E., Santiago J.V. The effect of puberty on the development of early diabetic microvascular disease in insulin-dependent diabetes. Diabetes Res Clin Pract 1987, 3(1):39-44.
5. Merimee T.J. A follow-up study of vascular disease in growth-hormone-deficient dwarfs with diabetes. N Engl J Med 1978, 298(22):1217-1222.
6. Adams D.A., Rand R.W., Roth N.H., Dashe A.M., Gipstein R.M., Heuser G. Hypophysectomy in diabetic retinopathy. The relationship between the degree of pituitary ablation and ocular response. Diabetes 1974, 23(8):698-707.
7. Grant M.B., Mames R.N., Fitzgerald C., et al. The efficacy of octreotide in the therapy of severe non-proliferative and early proliferative diabetic retinopathy: a randomized controlled study. Diabetes Care 2000, 23(4):504-509.
8. Varewijck A.J., Janssen J.A. Insulin and its analogs and their affinities to the IGF-1 receptor. Endocr Relat Cancer 2012.
9. Kurtzhals P., Schäffer L., Sørensen A., Kristensen C., Jonassen I., Schmid C., et al. Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use. Diabetes 2000, 49(6):999-1005.
10. Chantelau E., Kimmerle R., Meyer-Schwickerath R. Insulin, insulin analogues and diabetic retinopathy. Arch Physiol Biochem 2008, 114(1):54-62.
11. Zhang P., Liu N., Wang Y. Insulin may cause deterioration of proliferative diabetic retinopathy. Med Hypotheses 2009, 72(3):306-308.
12. Kitzmiller J.L., Main E., Ward B., Theiss T., Peterson D.L. Insulin lispro and the development of proliferative diabetic retinopathy during pregnancy. Diabetes Care 1999, 22(5):874-876.
13. Kubo Y., Hosoya K. Inner blood-retinal barrier transporters. In: Relevance to diabetic retinopathy. Diabetic Retinopathy. ISBN: 978-953-51-0044-7.
14. Sramek S.J., Wallow I.H., Stevens T.S., et al. Immunostaining of pre-retinal membranes for actin, fibronectin, and glial fibrillary acidic protein. Ophthalmol 1989, 96(6):835-841.
15. Weller M., Esser P., Heimann K., et al. Idiopathic proliferative vitreoretinopathy: activation of microglial cells as the deciding factor. Ophthalmol 1992, 89(5):387-390.
16. Esser P., Heimann K., Wiedemann P. Macrophages in proliferative vitreoretinopathy and proliferative diabetic retinopathy: differentiation of subpopulations. Br J Ophthalmol 1993, 77(11):731-733.
17. Hosoda Y., Okada M., Matsumura M., et al. Epiretinal membrane of proliferative diabetic retinopathy: an immunohistochemical study. Ophthal Res 1993, 25(5):289-294.
18. Mizutani M., Gerhardinger C., Lorenzi M. Muller cell changes in human diabetic retinopathy. Diabetes 1998, 47(3):445-449.
19. Fischer A.J., Scott M.A., Zelinka C., Sherwood P. A novel type of glial cell in the retina is stimulated by insulin-like growth factor 1 and may exacerbate damage to neurons and Müller glia. Glia 2010, 58(6):633-649.
20. Mukherjee S., Guidry C. The insulin-like growth factor system modulates retinal pigment epithelial cell tractional force generation. Invest Ophthalmol Vis Sci 2007, 48(4):1892-1899.
21. Hardwick C., Feist R., Morris R., et al. Tractional force generation by porcine Müller cells: stimulation by growth factors in human vitreous. Invest Ophthalmol Vis Sci 1997, 38(10):2053-2063.